申请人:Rorer Pharmaceutical Corporation
公开号:US04795757A1
公开(公告)日:1989-01-03
Compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, wherein: Ar is phenyl, naphthyl, heteroaryl, indole, or fused arylcycloalkyl optionally substituted with hydroxy, halo, CF.sub.3, NO.sub.2, C.sub.1-6 alkyl, C.sub.1-6 alkoxy or aryloxy; A and A' are each hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, hydroxy or aryloxy; X is cyano, nitro, COOR, SR, SOR or SOOR; R is H, C.sub.1-6 alkyl or aryl; n n' and n" are each 0 to 4; and m, m' and m" are each 1 to 4, have calcium channel blocking activity.
该化合物的结构式如下:##STR1##及其药用盐,其中:Ar为苯基、萘基、杂环芳基、吲哚基或融合芳基环烷基,可选择地取代为羟基、卤素、三氟甲基、硝基、C.sub.1-6烷基、C.sub.1-6烷氧基或芳氧基;A和A'均为氢、C.sub.1-6烷基、C.sub.1-6烷氧基、羟基或芳氧基;X为氰基、硝基、COOR、SR、SOR或SOOR;R为H、C.sub.1-6烷基或芳基;n、n'和n"均为0至4;m、m'和m"均为1至4,具有钙通道阻滞活性。